A conceptual framework for the molecular pathogenesis of progressive kidney disease

被引:12
作者
Schnaper, H. William [1 ,2 ]
Hubchak, Susan C. [1 ,2 ]
Runyan, Constance E. [1 ,2 ]
Browne, James A. [1 ,2 ]
Finer, Gal [1 ,2 ]
Liu, Xiaoying [1 ,2 ]
Hayashida, Tomoko [1 ,2 ]
机构
[1] Northwestern Univ, Div Kidney Dis, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Childrens Mem Hosp, Chicago, IL 60614 USA
关键词
Chronic kidney disease; Fibrosis; Kidney; Signal transduction; TRANSFORMING GROWTH FACTOR-BETA(1); TGF-BETA; ANGIOTENSIN-II; EXPRESSION; INJURY; CELLS; GLOMERULOSCLEROSIS; PODOCYTOPATHIES; NEPHROPATHY; APOPTOSIS;
D O I
10.1007/s00467-010-1503-4
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The data regarding the pathogenesis of progressive kidney disease implicate cytokine effects, physiological factors, and myriad examples of relatively nonspecific cellular dysfunction. The sheer volume of information being generated on this topic threatens to overwhelm our efforts to understand progression in chronic kidney disease or to derive rational strategies to treat it. Here, a conceptual framework is offered for organizing and considering these data. Disease is initiated by an injury that evokes a tissue-specific cellular response. Subsequent structural repair may be effective, or the new structure may be sufficiently changed that it requires an adaptive physiological response. If this adaptation is not successful, subsequent cycles of misdirected repair or maladaptation may lead to progressive nephron loss. To illustrate how this framework can be used to organize our approach to disease pathogenesis, the role of cytokines in proteinuria and progressive glomerular disease is discussed. Finally, this theoretical framework is reconsidered to examine its implications for the diagnosis and treatment of clinical conditions. Application of this schema could have significant relevance to both research inquiry and clinical practice.
引用
收藏
页码:2223 / 2230
页数:8
相关论文
共 52 条
[1]   A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome [J].
Araya, CE ;
Wasserfall, CH ;
Brusko, TM ;
Mu, W ;
Segal, MS ;
Johnson, RJ ;
Garin, EH .
PEDIATRIC NEPHROLOGY, 2006, 21 (05) :603-610
[2]  
August Phyllis, 2009, Trans Am Clin Climatol Assoc, V120, P61
[3]   A proposed taxonomy for the podocytopathies: A reassessment of the primary nephrotic diseases [J].
Barisoni, Laura ;
Schnaper, H. William ;
Kopp, Jeffrey B. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (03) :529-542
[4]  
Barisoni L, 2009, ARCH PATHOL LAB MED, V133, P201, DOI 10.1043/1543-2165-133.2.201
[5]  
BARNES JL, 1994, AM J PATHOL, V145, P585
[6]   Induction of TGF-β1 by the matricellular protein SPARC in a rat model of glomerulonephritis [J].
Bassuk, JA ;
Pichler, R ;
Rothmier, JD ;
Pippen, J ;
Gordon, K ;
Meek, RL ;
Bradshaw, AD ;
Lombardi, D ;
Strandjord, TP ;
Reed, M ;
Sage, EH ;
Couser, WG ;
Johnson, R .
KIDNEY INTERNATIONAL, 2000, 57 (01) :117-128
[7]  
BRICKER NS, 1978, NEW ENGL J MED, V299, P1287
[8]   Prevalence of chronic kidney disease in the United States [J].
Coresh, Josef ;
Selvin, Elizabeth ;
Stevens, Lesley A. ;
Manzi, Jane ;
Kusek, John W. ;
Eggers, Paul ;
Van Lente, Frederick ;
Levey, Andrew S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17) :2038-2047
[9]   Nitric oxide and vascular remodeling: Spotlight on the kidney [J].
Eberhardt, W. ;
Pfeilschifter, J. .
KIDNEY INTERNATIONAL, 2007, 72 :S9-S16
[10]   Reversal of lesions of diabetic nephropathy after pancreas transplantation [J].
Fioretto, P ;
Steffes, MW ;
Sutherland, DER ;
Goetz, FC ;
Mauer, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (02) :69-75